Direkt zum Inhalt
Merck

Characterization of microRNAs differentially expressed during bovine follicle development.

Reproduction (Cambridge, England) (2014-06-13)
Sadanand D Sontakke, Bushra T Mohammed, Alan S McNeilly, F Xavier Donadeu
ZUSAMMENFASSUNG

Several different miRNAs have been proposed to regulate ovarian follicle function; however, very limited information exists on the spatiotemporal patterns of miRNA expression during follicle development. The objective of this study was to identify, using microarray, miRNA profiles associated with growth and regression of dominant-size follicles in the bovine monovular ovary and to characterize their spatiotemporal distribution during development. The follicles were collected from abattoir ovaries and classified as small (4-8  mm) or large (12-17  mm); the latter were further classified as healthy or atretic based on estradiol and CYP19A1 levels. Six pools of small follicles and individual large healthy (n=6) and large atretic (n=5) follicles were analyzed using Exiqon's miRCURY LNA microRNA Array 6th gen, followed by qPCR validation. A total of 17 and 57 sequences were differentially expressed (greater than or equal to twofold; P<0.05) between large healthy and each of small and large atretic follicles respectively. Bovine miRNAs confirmed to be upregulated in large healthy follicles relative to small follicles (bta-miR-144, bta-miR-202, bta-miR-451, bta-miR-652, and bta-miR-873) were further characterized. Three of these miRNAs (bta-miR-144, bta-miR-202, and bta-miR-873) were also downregulated in large atretic follicles relative to large healthy follicles. Within the follicle, these miRNAs were predominantly expressed in mural granulosa cells. Further, body-wide screening revealed that bta-miR-202, but not other miRNAs, was expressed exclusively in the gonads. Finally, a total of 1359 predicted targets of the five miRNAs enriched in large healthy follicles were identified, which mapped to signaling pathways involved in follicular cell proliferation, steroidogenesis, prevention of premature luteinization, and oocyte maturation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Imidazol, ReagentPlus®, 99%
Sigma-Aldrich
Formamid, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Imidazol, ACS reagent, ≥99% (titration)
Sigma-Aldrich
Formamid, ≥99.5% (GC), BioReagent, Molecular Biology
Sigma-Aldrich
Imidazol, Molecular Biology, ≥99% (titration)
Sigma-Aldrich
Formamid, BioUltra, Molecular Biology, ≥99.5% (T)
Sigma-Aldrich
N-(3-Dimethylaminopropyl)-N′-ethyl-carbodiimid, ≥97.0% (T)
Sigma-Aldrich
Imidazol, BioUltra, ≥99.5% (GC)
Sigma-Aldrich
Progesteron, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Imidazol-Pufferlösung, BioUltra, 1 M in H2O
Sigma-Aldrich
Imidazol, puriss. p.a., ≥99.5% (GC)
Sigma-Aldrich
Progesteron, ≥99%
Sigma-Aldrich
Progesteron, meets USP testing specifications
Sigma-Aldrich
Formamid, spectrophotometric grade, ≥99%
Sigma-Aldrich
Progesteron, γ-irradiated, BioXtra, suitable for cell culture
Supelco
Progesteron, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Imidazol, ≥99% (titration), crystalline
Sigma-Aldrich
Imidazol, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99%
Sigma-Aldrich
Imidazol, BioUltra, Molecular Biology, ≥99.5% (GC)
Supelco
Imidazol, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Progesteron, United States Pharmacopeia (USP) Reference Standard
Supelco
Digoxigenin, analytical standard
USP
Imidazol, United States Pharmacopeia (USP) Reference Standard
Progesteron für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Progesteron, European Pharmacopoeia (EP) Reference Standard
Supelco
Formamid -Lösung, suitable for NMR (reference standard), 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
Progesteron für die Peakidentifizierung, European Pharmacopoeia (EP) Reference Standard
Supelco
Progesteron, VETRANAL®, analytical standard
Sigma-Aldrich
Imidazol, ReagentPlus®, 99%, Redi-Dri, free-flowing
Imidazol, European Pharmacopoeia (EP) Reference Standard